News

Institutional news
<p>Aznar Benitah receives the VI "Premio Nacional de Investigación en Cáncer 'Doctores Diz Pintado'" (from left to right) Eugenio Santo, Mª Ángeles Serrano, Salvador Aznar Benitah and Nicolás Rodríguez (USAL)</p>
30 Jan 2017

ICREA researcher and group leader of the Stem Cells and Cancer Laboratory at IRB Barcelona receives an award for his work on cancer.

The prize acknowledges Salvador Aznar Benitah's contributions to transferring knowledge from basic to clinical research.

Scientific news
<p>On the left, in vivo image of nanomachines using current microscopy techniques; on the right, the new method allows 3D observation of nanomachines in vivo and provides 25-fold improvement in resolution  (O. Gallego, IRB Barcelona)</p>
26 Jan 2017

Researchers headed by IRB Barcelona combine genetic engineering, super-resolution microscopy and biocomputation to allow them to see in 3D the protein machinery inside living cells

Published in the journal Cell, the study unveils key functional features of an assembly of proteins that is vital for animals and plants.

With this new strategy in hand, it will be possible to study cellular protein machinery in health and in disease.

Scientific news
<p>Staining of mouse liver sections showing steatosis of the liver (fatty liver), with accumulation of fat, lipid droplets (in red), within cells. Cell nuclei stain blue (C. Maíllo, IRB Barcelona).</p>
17 Jan 2017

It is a disease of the liver caused by excessive fat deposits in liver cells.

It is now the most prevalent chronic liver disease in industrialised countries and is a major public health concern because it leads to serious liver conditions.

 

Institutional news
<p>Participants of the “Crazy About Biomedicine”  2017 course.</p>
16 Jan 2017

IRB Barcelona organises a new year-long workshop in the life sciences within the series “Crazy About Science”, run by the Fundació Catalunya – La Pedrera.

“Crazy About Biomedicine” seeks to satisfy students’ interest in science and give them the chance to get a taste of what doing science in a top-class centre is like.

Scientific news
<p>Examples of computationally designed proteins made of curved beta-sheets and helices forming cavities with different sizes and shapes (E.Marcos, IRB Barcelona-UW)</p>
13 Jan 2017

The international team achieved it by discovering the rules behind a type of protein structures that are essential for the interaction between proteins and small molecules

IRB Barcelona researcher, Enrique Marcos, is the first author of the study published today in Science

Scientific news
<p>Ectopic wings upon ectopic activation of JAK/STAT (Carles Recasens-Alvarez and Ana Ferreira, IRB Barcelona)</p>
9 Jan 2017

Researchers at IRB Barcelona identify a fundamental role of the JAK/STAT signalling pathway in the development and growth regulation of limbs in Drosophila.

Published in Nature Communications, the study paves the way to research into the function of this pathway in vertebrate development and its possible involvement in human congenital diseases.

Institutional news
<p>Salvador Aznar Benitah, head of the IRB Barcelona group "Stem Cells and Cancer". (Photo: Battista-Minocri, IRB)</p>
28 Dec 2016

The VI National 'Doctores Diz Pintado' Cancer Research Prize acknowledges his work and scientific career.

Scientific news
<p>Despite the expanding repertoire of new anti-cancer agents, treatment failure remains a major challenge in the management of most advanced solid tumours, including breast cancer.</p>
20 Dec 2016

A bioinformatics analysis of pairing 64 drugs used to treat breast cancer allows researchers at IRB Barcelona to identify 10 previously untested combinations with potential to tackle resistance to breast cancer treatment.

In spite of the many drugs available to treat breast cancer, resistance continues to be a problem.

Institutional news
<p>Patrick Aloy, ICREA Research Professor & ERC Consolidator Grant.</p>
20 Dec 2016

The “Meet Our Scientists” video “Networks of life” explains his work and reveals the personal side of this scientist.

Scientific news
<p>Iproteos is currently performing the regulatory preclinical phase of its drug candidate for CIAS treatment.</p>
19 Dec 2016

Compound IPR19, a drug to stop the progression and reverse the cognitive deficits associated with schizophrenia.